These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15781586)

  • 1. The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation.
    Morinobu M; Nakamoto T; Hino K; Tsuji K; Shen ZJ; Nakashima K; Nifuji A; Yamamoto H; Hirai H; Noda M
    J Exp Med; 2005 Mar; 201(6):961-70. PubMed ID: 15781586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo.
    Chikazu D; Li X; Kawaguchi H; Sakuma Y; Voznesensky OS; Adams DJ; Xu M; Hoshio K; Katavic V; Herschman HR; Raisz LG; Pilbeam CC
    J Bone Miner Res; 2002 Aug; 17(8):1430-40. PubMed ID: 12162497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
    Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
    Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cnot7-null mice exhibit high bone mass phenotype and modulation of BMP actions.
    Washio-Oikawa K; Nakamura T; Usui M; Yoneda M; Ezura Y; Ishikawa I; Nakashima K; Noda T; Yamamoto T; Noda M
    J Bone Miner Res; 2007 Aug; 22(8):1217-23. PubMed ID: 17451368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6.
    Zachos TA; Shields KM; Bertone AL
    J Orthop Res; 2006 Jun; 24(6):1279-91. PubMed ID: 16649180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of a mesenchymal cell line that differentiates into osteoblasts in response to BMP-2 from calvariae of GFP transgenic mice.
    Kadowaki A; Tsukazaki T; Hirata K; Shibata Y; Okubo Y; Bessho K; Komori T; Yoshida N; Yamaguchi A
    Bone; 2004 Jun; 34(6):993-1003. PubMed ID: 15193545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased bone morphogenetic protein-6 expression in mouse long bones after estrogen administration.
    Plant A; Tobias JH
    J Bone Miner Res; 2002 May; 17(5):782-90. PubMed ID: 12009008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative regulation of bone morphogenetic protein/Smad signaling by Cas-interacting zinc finger protein in osteoblasts.
    Shen ZJ; Nakamoto T; Tsuji K; Nifuji A; Miyazono K; Komori T; Hirai H; Noda M
    J Biol Chem; 2002 Aug; 277(33):29840-6. PubMed ID: 12023967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.
    Li Y; Li A; Strait K; Zhang H; Nanes MS; Weitzmann MN
    J Bone Miner Res; 2007 May; 22(5):646-55. PubMed ID: 17266397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
    Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
    J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drynariae Rhizoma promotes osteoblast differentiation and mineralization in MC3T3-E1 cells through regulation of bone morphogenetic protein-2, alkaline phosphatase, type I collagen and collagenase-1.
    Jeong JC; Lee JW; Yoon CH; Kim HM; Kim CH
    Toxicol In Vitro; 2004 Dec; 18(6):829-34. PubMed ID: 15465649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cartilage-derived morphogenetic proteins enhance the osteogenic protein-1-induced osteoblastic cell differentiation of C2C12 cells.
    Yeh LC; Tsai AD; Zavala MC; Lee JC
    J Cell Physiol; 2004 Dec; 201(3):401-8. PubMed ID: 15389555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
    Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying genes that regulate bone remodeling as potential therapeutic targets.
    Krane SM
    J Exp Med; 2005 Mar; 201(6):841-3. PubMed ID: 15781576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMP-2 promotes differentiation of osteoblasts and chondroblasts in Runx2-deficient cell lines.
    Liu T; Gao Y; Sakamoto K; Minamizato T; Furukawa K; Tsukazaki T; Shibata Y; Bessho K; Komori T; Yamaguchi A
    J Cell Physiol; 2007 Jun; 211(3):728-35. PubMed ID: 17226753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.
    Morvan F; Boulukos K; Clément-Lacroix P; Roman Roman S; Suc-Royer I; Vayssière B; Ammann P; Martin P; Pinho S; Pognonec P; Mollat P; Niehrs C; Baron R; Rawadi G
    J Bone Miner Res; 2006 Jun; 21(6):934-45. PubMed ID: 16753024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts.
    Wu JB; Fong YC; Tsai HY; Chen YF; Tsuzuki M; Tang CH
    Eur J Pharmacol; 2008 Jul; 588(2-3):333-41. PubMed ID: 18495116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells.
    Susperregui AR; Viñals F; Ho PW; Gillespie MT; Martin TJ; Ventura F
    J Cell Physiol; 2008 Jul; 216(1):144-52. PubMed ID: 18247361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells.
    Maeda S; Hayashi M; Komiya S; Imamura T; Miyazono K
    EMBO J; 2004 Feb; 23(3):552-63. PubMed ID: 14749725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of CIZ, a nucleocytoplasmic shuttling protein, prevents unloading-induced bone loss through the enhancement of osteoblastic bone formation in vivo.
    Hino K; Nakamoto T; Nifuji A; Morinobu M; Yamamoto H; Ezura Y; Noda M
    Bone; 2007 Apr; 40(4):852-60. PubMed ID: 17301008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.